Abstract
Vitiligo is one of the commonest pigmentary disorders characterized by destruction of melanocytes. To evaluate the efficacy of topical bimatoprost ophthalmic solution in stable facial vitiligo. Eight cases of stable facial vitiligo were treated with bimatoprost 0.03% ophthalmic solution once daily for 12 weeks. Photographic records were taken at 2 weeks follow-up along with dermoscopic (Polarized, 10×) evaluation. Four cases had excellent repigmentation, two cases had partial repigmentation and two cases had poor response. Bimatoprost seems to be promising in treating stable vitiligo but large-scale studies are required.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
